Benziodarone
Benziodarone
Benziodarone (pronounced ben-zee-oh-dar-own) is a pharmaceutical drug used primarily for the treatment of gout. It belongs to the class of medications known as uricosuric agents, which work by increasing the excretion of uric acid in the urine, thereby reducing the concentration of uric acid in the body.
Etymology
The term "Benziodarone" is derived from the chemical structure of the drug, which contains a benzene ring (benz-) and an iodine atom (-iod-), along with a darone group (-darone), a common suffix for drugs that affect the cardiovascular system.
Usage
Benziodarone is used to treat gout, a type of arthritis that occurs when uric acid builds up in the blood and causes joint inflammation. It is also sometimes used to treat hyperuricemia, a condition characterized by high levels of uric acid in the blood.
Related Terms
- Uricosuric agents: A class of drugs that increase the excretion of uric acid in the urine.
- Gout: A type of arthritis that occurs when uric acid builds up in the blood and causes joint inflammation.
- Hyperuricemia: A condition characterized by high levels of uric acid in the blood.
- Benzene ring: A hexagonal arrangement of carbon atoms, common in organic chemistry.
- Iodine: A chemical element with the symbol I and atomic number 53.
- Darone: A common suffix for drugs that affect the cardiovascular system.
External links
- Medical encyclopedia article on Benziodarone
- Wikipedia's article - Benziodarone
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski